Science Market Update

UC Davis: Major Cancer Research Funding Awarded by NCI

Posted by Rebecca Inch-Partridge on Thu, Sep 13, 2018

UC Davis Medical Center is home to one of only 49 National Cancer Institute (NCI) designated comprehensive cancer centers. The UC Davis Center is the only comprehensive cancer center in California’s Central Valley and inland northern California. It serves a region with a population of roughly 6 million people. The Center has $63 million in NHI and California Healthcare Institute funding.  

The NCI, a division of the NIH, awards University of California, Davis roughly $200 million annually to conduct cancer research.  

Here are the top 5 NCI grants this year:

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, Oncology, Cancer Immunotherapy, Cancer Science, Comprehensive Cancer Center, cancer research funding, NIH funded Research Projects, biotech vendor show

UC Davis Receives $2.5 Million Cancer Research Grant

Posted by BCI Staff on Fri, May 18, 2018

Last Fall, UC Davis' Comprehensive Cancer Center  received its first National Cancer Institute (NCI) Moonshot Grant of $2.5 million to research two types of cancers in dogs that are very similar to cancer in humans. 

UC Davis boasts both a world renowned veterinary school and medical school. Researchers are equipped with the tools to examine the link between cancer in dogs and cancer in humans. UC Davis has a Comparative Oncology Program at the Comprehensive Cancer Center, one of very few in the nation.

The program allows for veterinarians and physicians to work together to find creative cancer solutions. Robert Canter, a surgical oncologist at the Davis Comprehensive Cancer Center, and Robert Rehun, a veterinary oncologist, plan to conduct various research trials with the Moonshot Grant.

The trials will be focused on isolating dogs' natural killer cells. Killer cells are white blood cells that are particulary good at eliminating cells infected with viruses or cancer cells. Once the killer cells are isolated, researchers hope to connect the killer cells with human IL15. IL15 is a cytokine that might help activate the killer cells in human patients. 

This study is just one example of the many different projects that UC Davis facilitates to help advance cancer research. This past year, the Davis Comprehensive Cancer Center received $7.3 million in support. The Biomedical Technology Program at the Cancer Center alone has over 20 active projects and almost $24 million in funding.

 

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, 2018, Oncology, Cancer Immunotherapy

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News